Browse hierarchy: [Neurology (NE)](/submissions/NE) → [Subpart F — Neurological Therapeutic Devices](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices) → [21 CFR 882.5060](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/882.5060) → OBV — Eating Disorder Conditioning Tool

# OBV · Eating Disorder Conditioning Tool

_Neurology · 21 CFR 882.5060 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/OBV

## Overview

- **Product Code:** OBV
- **Device Name:** Eating Disorder Conditioning Tool
- **Regulation:** [21 CFR 882.5060](/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/882.5060)
- **Device Class:** 2
- **Review Panel:** [Neurology](/submissions/NE)

## Identification

A conditioning tool for eating disorders is a prescription device that non-invasively measures the mass of food eaten during a meal and provides feedback in the form of eating rate, patient satiety, and eating pattern information to the patient.

## Classification Rationale

Class II (special controls). The special controls for this device are:

## Special Controls

*Classification.* Class II (special controls). The special controls for this device are:(1) Nonclinical performance testing must demonstrate:
(i) Device measurement accuracy and repeatability; and
(ii) Device feedback accuracy.
(2) Software verification, validation, and hazard analysis must be performed.
(3) The patient-contacting components of the device must be demonstrated to be biocompatible.
(4) Performance testing must demonstrate the electromagnetic compatibility (EMC) and electrical safety of the device.
(5) Labeling and patient labeling must be provided which includes the following:
(i) Information identifying and explaining how to use the device and its components; and
(ii) Information on how the device operates and the typical course of treatment.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN070014](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/OBV/DEN070014.md) | MANDOMETER III | Ab Mando | Mar 31, 2011 | DENG |

## Top Applicants

- Ab Mando — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/OBV](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94neurological-therapeutic-devices/OBV)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com